Headway

Grow Therapy

Headway

Headway makes money by taking a percentage of the insurance reimbursement for each session facilitated through the platform. When a patient sees a Headway-credentialed therapist and pays their copay, Headway processes the insurance claim and takes a service fee from the reimbursement before paying the therapist.

The model aligns incentives well. Headway only makes money when therapy sessions actually happen, which means they're incentivized to help therapists see more patients and reduce no-shows.

Therapists make more than they would on their own (because Headway's negotiated rates are often better than individual therapists can get), and patients pay only their insurance copay ($0-$50 typically) instead of full out-of-pocket rates.

Scale creates a data and negotiation advantage. With 40,000+ therapists on the platform, Headway can negotiate better reimbursement rates with insurers.

More therapists attract more patients. More patients justify better rates.

The flywheel spins.

Grow Therapy

Two-sided marketplace for mental health. Therapists join Grow Therapy's network and the company handles insurance credentialing, claims billing, scheduling, and compliance.

In return, Grow Therapy takes a percentage of each session's insurance reimbursement. Patients search Grow Therapy's directory to find in-network therapists by specialty, insurance plan, and availability.

The therapist gets to focus on therapy. The patient gets affordable care.

Grow Therapy gets a cut for handling the business side. Everyone wins except the old credentialing companies that charged therapists thousands of dollars to do what Grow Therapy does for free.

Headway

Andrew Adams and Jake Sussman founded Headway in 2019 after watching people in their lives struggle to access affordable mental healthcare. The problem was specific and structural: most therapists operate as solo practitioners who don't accept insurance.

Not because they don't want to — because the process of getting credentialed with insurance companies, submitting claims, and chasing reimbursements is so bureaucratically painful that most therapists give up and go cash-only.

The result is a two-tier mental healthcare system. People with money pay $150-$300 per session out of pocket.

People without money either can't afford therapy or wait months for the few in-network providers available. Meanwhile, therapists who only accept cash are leaving money on the table — insurance pays reliably once the system works, and the patient pool is vastly larger.

Headway's solution was to build the infrastructure layer that makes insurance billing painless for therapists. They handle credentialing (getting the therapist accepted into insurance networks), claims submission, payment processing, and compliance — all the administrative work that therapists hate.

The therapist shows up, does therapy, and Headway handles everything else.

Grow Therapy

Jake Cooper was working in healthcare operations when he saw the same problem from both sides. Patients couldn't find therapists who accepted their insurance.

Therapists wanted to accept insurance but the credentialing process took 6 to 12 months and the billing was a bureaucratic disaster. Most therapists just went cash-pay to avoid the headache, which meant only people who could afford $200 a session got care.

Cooper started Grow Therapy in 2020 to solve the plumbing problem. Not the clinical side — the administrative infrastructure that makes it possible for a therapist to see an insured patient without losing their mind.

He launched right as the pandemic made therapy demand explode and supply couldn't keep up.

Headway

Headway grew by solving the supply-side problem first. If you can get enough therapists on the platform and credentialed with insurance, patients will come because affordable therapy is in massive demand.

They recruited therapists with a compelling pitch: "keep doing therapy, we'll handle the business side."

Insurance partnerships were the growth unlock. Headway partnered with major insurance companies (Aetna, Cigna, United Healthcare, Anthem) to become an authorized credentialing partner.

This meant Headway could get therapists in-network faster and with less friction than the traditional process.

The mental health destigmatization wave amplified demand. Post-COVID, demand for therapy skyrocketed.

The conversation around mental health became mainstream. Headway was positioned perfectly to absorb that demand by connecting patients with affordable, insurance-covered therapists.

Grow Therapy

Supply-side acquisition — recruit therapists by solving their biggest pain point (insurance credentialing) for free. Once therapists are in-network through Grow Therapy, patients find them through the directory.

The company expanded insurance partnerships aggressively, getting in-network with Aetna, Cigna, UnitedHealthcare, Anthem, and dozens of regional plans. State-by-state expansion tracking licensing requirements.

Content marketing targeting therapists frustrated with private practice admin. Referral loops from satisfied therapists bringing colleagues onto the platform.

Headway

Therapist retention is a challenge. Solo practitioners are independent by nature, and some leave the platform once they've built a full patient roster through Headway.

The platform needs to continuously demonstrate value beyond initial credentialing to keep therapists from going direct.

Insurance reimbursement rates are notoriously low. Therapists who accept insurance often earn 30-50% less per session than cash-pay rates.

While Headway negotiates better rates than individual therapists typically get, the fundamental economics of insurance-based mental healthcare remain challenging.

Regulatory complexity varies by state. Each state has different licensing requirements, insurance regulations, and telehealth rules.

Expanding to all 50 states means navigating 50 different regulatory frameworks, each with their own credentialing requirements and compliance standards.

Grow Therapy

Insurance reimbursement rates for therapy are low and getting lower in some states. Grow Therapy's margin depends on volume because per-session economics are thin.

Keeping therapists on the platform once they're credentialed is a retention challenge — some therapists use Grow Therapy to get credentialed, then leave to handle billing themselves. Competition from Headway, Alma, and others doing similar things means the race to sign up therapists is intense.

Quality control across 10,000+ providers is a real concern. And the fundamental tension remains: insurance companies want to pay less per session, therapists need to earn enough to survive, and Grow Therapy sits in the middle trying to make both sides happy.

Headway

Headway Provider Platform — the core system where therapists manage their practice: scheduling, credentialing, claims submission, payment tracking, and patient communications. Headway Patient Matching — a directory and matching service that connects patients with in-network therapists based on insurance, location, specialty, and availability.

Insurance Credentialing Service — Headway handles the months-long process of getting therapists accepted into insurance networks, reducing what typically takes 6-12 months to weeks. Claims and Billing Engine — automated insurance claims submission and tracking that eliminates the paperwork therapists dread.

Practice Management Tools — scheduling, intake forms, session notes, and telehealth capabilities integrated into one platform.

Grow Therapy

Insurance credentialing — gets therapists paneled with major insurers in weeks instead of months. Automated billing and claims processing that eliminates the denied-claim nightmare.

A patient-facing directory with filters for insurance, specialty, location, and availability. Practice management tools including scheduling, intake forms, and session notes.

Telehealth platform built in so therapists don't need separate video software. Group practice support for therapists who want to scale beyond solo practice.

Headway

Andreessen Horowitz led the Series C at a $2.3 billion valuation. Accel and Thrive Capital invested in earlier rounds.

GV (Google Ventures) and Spark Capital also participated. The company has raised approximately $226 million total.

Grow Therapy

Investors include Sequoia Capital, TCV, Signalfire, and SVB Capital. Series C in 2023 valued the company at over $1 billion.